España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Barinthus Biotherapeutics
BRNS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Barinthus Biotherapeutics (BRNS) Forecast
News
Earnings
Barinthus Biotherapeutics (BRNS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Barinthus Biotherapeutics (NASDAQ:BRNS) Stock
Barinthus Biotherapeutics Stock (NASDAQ: BRNS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Friday, November 15, 2024
Arbutus And Barinthus Bio Report IM-PROVE II ...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Wednesday, November 06, 2024
Barinthus Biotherapeutics shares are trading ...
Benzinga Newsdesk
Barinthus Biotherapeutics Q3 EPS $(0.21) Beat...
Benzinga Newsdesk
Tuesday, October 01, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Barinthus Reports Completion Of Enrollment Fo...
Benzinga Newsdesk
Thursday, September 26, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Tuesday, September 24, 2024
Barinthus Bio Begins Phase 1 Trial Of VTP-100...
Benzinga Newsdesk
Tuesday, August 13, 2024
Alliance Global Partners Maintains Buy on Bar...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Thursday, August 08, 2024
Barinthus Biotherapeutics Q2 EPS $(0.43) Miss...
Benzinga Newsdesk
Friday, June 21, 2024
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, June 13, 2024
Barclays Maintains Overweight on Barinthus Bi...
Benzinga Newsdesk
Wednesday, June 12, 2024
Barinthus Bio To Prioritize Development Of VT...
Benzinga Newsdesk
Friday, June 07, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Wednesday, June 05, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, May 22, 2024
Barinthus Bio To Present VTP-300 Clinical Upd...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Monday, May 13, 2024
Barinthus Biotherapeutics Q1 EPS $(0.40) Beat...
Benzinga Newsdesk
Wednesday, May 01, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, April 22, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Friday, April 19, 2024
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives
Vandana Singh
Thursday, April 18, 2024
Barinthus Bio Announces Topline Data From Pha...
Benzinga Newsdesk
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, April 03, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Thursday, March 21, 2024
HC Wainwright & Co. Maintains Buy on Barinthu...
Benzinga Newsdesk
Wednesday, March 20, 2024
Barinthus Biotherapeutics: Q4 Earnings Insights
Benzinga Insights
Tuesday, March 19, 2024
Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
Zacks
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, December 21, 2023
Barinthus Biotherapeutics Collaborates With C...
Benzinga Newsdesk
Tuesday, November 28, 2023
HC Wainwright & Co. Reiterates Buy on Barinth...
Benzinga Newsdesk
Thursday, November 09, 2023
Barinthus Biotherapeutics Q3 EPS $(0.37) Down...
Benzinga Newsdesk
Barinthus Bio Said Initial Data From The Combination Of Imdusiran And VTP-300 Show Meaningful Reductions Of HBsAg Levels That Were Maintained Well Below Baseline.
Charles Gross
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
